Urine synaptopodin excretion is an important marker of glomerular disease progression
- PMID: 27604800
- PMCID: PMC5016285
- DOI: 10.3904/kjim.2015.226
Urine synaptopodin excretion is an important marker of glomerular disease progression
Abstract
Background/aims: Podocytes play an important role in maintaining the glomerular filtration barrier and in formation of the slit diaphragm. Podocyte loss is associated with chronic kidney disease progression, but it is not clear whether urinary podocyte proteins in urine reflect the clinical extent of glomerular damage. We investigated the correlation between the amounts of urinary podocyte proteins and renal function and albuminuria.
Methods: The study enrolled 33 patients with diabetic kidney disease or glomerular disease and measured urinary podocytes proteins using Western blotting. Urinary podocyte proteins were measured according to the density of the bands on Western blotting. We measured serum creatinine and the spot urine albumin/creatinine ratio as markers of renal damage, and compared the correlation of urinary podocyte protein in the glomerular disease patients.
Results: The mean patient age was 49.3 ± 16.5 years, the mean serum creatinine level was 2.30 ± 1.76 mg/dL, and the mean albumin/creatinine ratio was 4.85 ± 3.52. Among the podocyte proteins, urine synaptopodin showed strong correlation with serum creatinine by multivariate regression analysis (p < 0.001) and showed linear correlation (r = 0.429, p < 0.01). Urine podocyte proteins were increased in patients with diabetes, and synaptopodin showed the greatest significant difference (7.68 ± 5.61 vs. 2.56 ± 3.11, p < 0.001), but this might be associated with renal impairment. The urine albumin excretion did not differ between the diabetics and non-diabetics (p = 0.73).
Conclusions: Urine synaptopodin is associated with serum creatinine elevation in the patients with glomerulonephritis including diabetic kidney disease regardless of urine albumin excretion. We suggest that the urine synaptopodin level can predict glomerular damage independently of the urine albumin excretion.
Keywords: Glomerulonephritis; Kidney injury; Podocytes; Proteinuria; Synaptopodin.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures



Similar articles
-
Increased Urinary Excretion of Podocyte Markers in Normoalbuminuric Patients with Diabetes.Nephron. 2015;131(1):34-42. doi: 10.1159/000438493. Epub 2015 Sep 5. Nephron. 2015. PMID: 26340089
-
Increasing urinary podocyte mRNA excretion and progressive podocyte loss in kidney contribute to the high risk of long-term renal disease caused by preterm birth.Sci Rep. 2021 Oct 19;11(1):20650. doi: 10.1038/s41598-021-00130-y. Sci Rep. 2021. PMID: 34667204 Free PMC article.
-
Urine excretion of protein HC in proteinuric glomerular diseases correlates to urine IgG but not to albuminuria.Kidney Int. 2001 Nov;60(5):1904-9. doi: 10.1046/j.1523-1755.2001.00018.x. Kidney Int. 2001. PMID: 11703609
-
Proteinuria: detection and role in native renal disease progression.Transplant Rev (Orlando). 2012 Jan;26(1):3-13. doi: 10.1016/j.trre.2011.10.002. Transplant Rev (Orlando). 2012. PMID: 22137726 Review.
-
Urine markers of podocyte dysfunction: a review of podocalyxin and nephrin in selected glomerular diseases.Biomark Med. 2018 Aug;12(8):927-935. doi: 10.2217/bmm-2018-0152. Epub 2018 Jul 6. Biomark Med. 2018. PMID: 29976076 Review.
Cited by
-
Effects of SGLT2 inhibitors on patients with diabetic kidney disease: A preliminary study on the basis of podocyturia.J Diabetes. 2022 Apr;14(4):236-246. doi: 10.1111/1753-0407.13261. Epub 2022 Feb 28. J Diabetes. 2022. PMID: 35229458 Free PMC article.
-
Urinary podocyte markers in diabetic kidney disease.Kidney Res Clin Pract. 2024 May;43(3):274-286. doi: 10.23876/j.krcp.23.109. Epub 2024 Feb 6. Kidney Res Clin Pract. 2024. PMID: 38325865 Free PMC article.
-
Spatio-temporal patterning of different connexins in developing and postnatal human kidneys and in nephrotic syndrome of the Finnish type (CNF).Sci Rep. 2020 May 29;10(1):8756. doi: 10.1038/s41598-020-65777-5. Sci Rep. 2020. PMID: 32471989 Free PMC article.
-
A Review of Specific Biomarkers of Chronic Renal Injury and Their Potential Application in Nonclinical Safety Assessment Studies.Toxicol Pathol. 2021 Jul;49(5):996-1023. doi: 10.1177/0192623320985045. Epub 2021 Feb 12. Toxicol Pathol. 2021. PMID: 33576319 Free PMC article. Review.
-
Disease predictability review using common biomarkers appearing in diabetic nephropathy and neurodegeneration of experimental animals.Lab Anim Res. 2022 Feb 7;38(1):3. doi: 10.1186/s42826-022-00113-8. Lab Anim Res. 2022. PMID: 35130988 Free PMC article. Review.
References
-
- Rutherford WE, Blondin J, Miller JP, Greenwalt AS, Vavra JD. Chronic progressive renal disease: rate of change of serum creatinine concentration. Kidney Int. 1977;11:62–70. - PubMed
-
- Fornoni A. Proteinuria, the podocyte, and insulin resistance. N Engl J Med. 2010;363:2068–2069. - PubMed
-
- Toyoda M, Najafian B, Kim Y, Caramori ML, Mauer M. Podocyte detachment and reduced glomerular capillary endothelial fenestration in human type 1 diabetic nephropathy. Diabetes. 2007;56:2155–2160. - PubMed
-
- Yu D, Petermann A, Kunter U, Rong S, Shankland SJ, Floege J. Urinary podocyte loss is a more specific marker of ongoing glomerular damage than proteinuria. J Am Soc Nephrol. 2005;16:1733–1741. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical